Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kristin Sedgwick"'
Synchronous Onset of Breast and Pancreatic Cancers: Results of Germline and Somatic Genetic Analysis
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 2, Pp 387-394 (2016)
Background: Synchronous cancers have occasionally been detected at initial diagnosis among patients with breast and ovarian cancer. However, simultaneous coexistence and diagnosis of breast and pancreas cancer has not previously been reported. Case R
Externí odkaz:
https://doaj.org/article/004c4cbaa6da473a9076ccb55e938205
Autor:
Kyrillus Samaan Shohdy, Dario Martin Villamar, Yen Cao, Janson Trieu, Kristin Sedgwick Price, Rebecca Nagy, Scott T. Tagawa, Ana M. Molina, Cora N. Sternberg, David M. Nanus, Petros Grivas, Guru P. Sonpavde, Juan Miguel Mosquera, Olivier Elemento, Nicholas J. Vogelzang, Bishoy Morris Faltas
Publikováno v:
Journal of Clinical Oncology. 40:532-532
532 Background: It is not known whether serial circulating tumor DNA (ctDNA) can augment imaging for assessing treatment response in patients (pts.) with advanced urothelial carcinoma (UC). We hypothesized that serial ctDNA measurements predict the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68f04849ce9c0775c50dd24657ebd848
https://doi.org/10.1200/jco.2022.40.6_suppl.532
https://doi.org/10.1200/jco.2022.40.6_suppl.532
Autor:
Yuichiro Tsukada, Nobuhisa Matsuhashi, Tatsuro Murano, Manabu Shiozawa, Takeshi Kato, Eiji Oki, Masahiro Goto, Yoshinori Kagawa, Akiyoshi Kanazawa, Takashi Ohta, Akira Ouchi, Hideaki Bando, Xiaotong Zuo, Princy Parsana, Kristin Sedgwick Price, Hiroaki Ikematsu, Takayuki Yoshino, Yoshiaki Nakamura
Publikováno v:
Journal of Clinical Oncology. 40:168-168
168 Background: Identifying molecular residual disease (MRD) using circulating tumor DNA (ctDNA) analysis after curative surgery can potentially stratify the recurrence risk and facilitate personalization of adjuvant treatment in patients with colore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be2c1999ddae4bac68ef17e04f9f8d26
https://doi.org/10.1200/jco.2022.40.4_suppl.168
https://doi.org/10.1200/jco.2022.40.4_suppl.168
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Challenges in Interpreting Germline Mutations in BARD1 and ATM in Breast and Ovarian Cancer Patients
Autor:
Kristin Sedgwick, Olga Voznesensky, Steven P. Balk, Nadine Tung, Erin Hofstatter, Kimberly R. DeLeonardis, Ellen T. Matloff
Publikováno v:
The Breast Journal. 23:461-464
Next-generation sequencing promotes identification of mutations in non-BRCA1/2 genes in hereditary cancer families. The contribution of mutations in moderate penetrance genes to hereditary cancer risk is not well established. Here, we report a family
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a8dfa72f062e5827946672753dc4717
https://doi.org/10.1111/tbj.12764
https://doi.org/10.1111/tbj.12764
Synchronous Onset of Breast and Pancreatic Cancers: Results of Germline and Somatic Genetic Analysis
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 9, Iss 2, Pp 387-394 (2016)
Case Reports in Oncology, Vol 9, Iss 2, Pp 387-394 (2016)
Background: Synchronous cancers have occasionally been detected at initial diagnosis among patients with breast and ovarian cancer. However, simultaneous coexistence and diagnosis of breast and pancreas cancer has not previously been reported. Case R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4326b7e0eb41521fde692fa20a2eab5b
http://europepmc.org/articles/PMC5043351
http://europepmc.org/articles/PMC5043351
Autor:
Kristin Sedgwick, Kirsten Timms, Benjamin B. Roa, Nadine Tung, Richard J. Wenstrup, Anne-Renee Hartman, Brian Allen, Judy Garber, Kathleen A. Soltis, Leif W. Ellisen, Jill Krejdovsky, Christina I. Herold, Chiara Battelli, Kim DeLeonardis, Satish Bhatnagar, Karla R. Bowles, Rajesh R. Kaldate
Publikováno v:
Cancer. 121:25-33
BACKGROUND Next-generation sequencing (NGS) allows for simultaneous sequencing of multiple cancer susceptibility genes and, for an individual, may be more efficient and less expensive than sequential testing. The authors assessed the frequency of del
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6467372be16c4bd5357faaffe1605274
https://doi.org/10.1002/cncr.29010
https://doi.org/10.1002/cncr.29010
Autor:
Kristin Sedgwick Price, Lesli Ann Kiedrowski, Fernando I. De Zarraga, Mike Cusnir, Richard B. Lanman, Rebecca J Nagy
Publikováno v:
Journal of Clinical Oncology. 37:237-237
237 Background: Metastatic pancreatic cancer (mPC) is one of the deadliest cancers with a < 10% 5-year survival rate. Poor prognosis is well established with lack of response to or rapid progression on existing chemotherapy options. Targeted therapie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef1b76c948de3412ceeea4b1a5499126
https://doi.org/10.1200/jco.2019.37.4_suppl.237
https://doi.org/10.1200/jco.2019.37.4_suppl.237
Autor:
Nadine, Tung, Chiara, Battelli, Brian, Allen, Rajesh, Kaldate, Satish, Bhatnagar, Karla, Bowles, Kirsten, Timms, Judy E, Garber, Christina, Herold, Leif, Ellisen, Jill, Krejdovsky, Kim, DeLeonardis, Kristin, Sedgwick, Kathleen, Soltis, Benjamin, Roa, Richard J, Wenstrup, Anne-Renee, Hartman
Publikováno v:
Cancer. 121(1)
Next-generation sequencing (NGS) allows for simultaneous sequencing of multiple cancer susceptibility genes and, for an individual, may be more efficient and less expensive than sequential testing. The authors assessed the frequency of deleterious ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a7e69fa73e10243c274bc4937bcf3f28
https://pubmed.ncbi.nlm.nih.gov/25186627
https://pubmed.ncbi.nlm.nih.gov/25186627